Accuracy of Identification of Patients with Immune Thrombocytopenic Purpura Through Administrative Records: A Data Validation Study

American Journal of Hematology

Volumn 75, Issue 1, 2004, Pages 12-17

  Segal, Jodi B ^a,c,d   Powe, Neil R ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Administrative data; ICD 9 CM; Immune thrombocytopenic purpura; Validity

Indexed keywords

ARTICLE; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HOSPITAL PATIENT; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTPATIENT; PRIORITY JOURNAL; VALIDATION PROCESS;

ACCOUNTS PAYABLE AND RECEIVABLE; CROSS-SECTIONAL STUDIES; HUMANS; INPATIENTS; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORDS; OUTPATIENTS; POPULATION SURVEILLANCE; PURPURA, THROMBOCYTOPENIC; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0346786468     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10445     Document Type: Article

References (28)

1. Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization in Project (HCUP), September 2002. Rockville, MD: Agency for Healthcare Research and Quality; 2002.http://www.ahrq.gov/data/hcup/hcupnis.htm
2. Nationwide Ambulatory Medical Care Survey, May 2001. Hyattsville, MD: National Center for Health Statistics of the Centers for Disease Control and Prevention: 2001. http://www.cdc.gov/nchs/about/major/ahcd/namcsdcs.htm
3. Watanabe CT, Maynard C, Ritchie JL. Short-term outcomes after percutaneous coronary intervention: effects of stenting and institutional volume shifts. Am Heart J 2002;144:310-314.
4. Watanabe CT, Maynard C, Ritchie JL. Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol 2001;88:848-852.
5. Behrendt CE. Acute respiratory failure in the United States: incidence and 31-day survival. Chest 2000;118:1100-1105.
6. Segal JB, Guallar E, Powe NR. Autologous blood transfusion in the United States: clinical and nonclinical determinants of use. Transfusion 2001;41:1539-1547.
7. Publications from the HCUP Database, September 2002. Rockville, MD: Agency for Healthcare Research and Quality; 2002. http:// www.ahrq.gov/data/hcup/hcupref.htm.
8. Strom BL, Carson JL, Schinnar R, Shaw M. Is cimetidine associated with neutropenia? Am J Med 1995;99:282-290.
9. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M. Descriptive epidemiology of agranulocytosis. Arch Intern Med 1992;152:1475-1480.
10. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Lundin FE Jr. Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 1993;153:2119-2124.
11. Breitfeld PP, Dale T, Kohne J, Hui S, Tierney WM. Accurate case finding using linked electronic clinical and administrative data at a children's hospital. J Clin Epidemiol 2001;54:1037-1045.
12. Madsen K, Rosenman M, Hui S, Breitfeld PP. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol 2002;24:256-262.
13. Rosenman M, Madsen K, Hui S, Breitfeld PP. Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges. J Pediatr Hematol Oncol 2002;24:263-268.
14. Nietert PJ, Abboud MR, Zoller JS, Silverstein MD. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol 1999;21:389-396.
15. Surgenor DM, Wallace EL, Churchill WH, Hao S, Hale WB, Schnitzer J. Utility of DRG and ICD-9-CM classification codes for the study of transfusion issues. Transfusion in patients with digestive diseases. Transfusion. 1989;29:761-767.
16. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
17. Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: progress has been made. but problems remain. Am J Public Health 1992;82:243-248.
18. Holt G, Feurer ID, Schwartz HS. An analysis of concordance among hospital databases and physician records. Ann Surg Oncol 1998;5:553-556.
19. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002;40:675-685.
20. Delaney AM, Hsai DC. National DRG validation study: final report. Waltham, MA: Baxter Health Data Institute; 1987.
21. Segal JB, Ness PM, Powe NR. Validation billing data for RBC transfusions: a brief report. Transfusion 2001;41:530-533.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
23. Simpson KN, Coughlin CM, Eron J, Bussel JB. Idiopathic thrombocytopenia purpura: treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy. Semin Hematol 1998;35:58-64.
24. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
25. Gordis L. Assessing the validity and reliability of diagnostic and screening tests. In: Epidemiology. Philadelphia: W.B. Saunders Company; 1996. p 58-76.
26. Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf 2001;10:389-392.
27. Varmus H. Evaluating the burden of disease and spending the research dollars of the National Institutes of Health. N Engl J Med 1999;340:1914-1915.
28. Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999;340:1881-1887.